Ovation Science Inc. (CSE:OVAT)

Market Cap	768.83K -45.5%
Revenue (ttm)	57.34K -11.4%
Net Income	-657.40K
EPS	-0.02
Shares Out	38.44M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	20,000
Open	0.0200
Previous Close	0.0200
Day's Range	0.0200 - 0.0200
52-Week Range	0.0150 - 0.0500
Beta	0.71
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 20, 2026

About Ovation Science

Ovation Science Inc. engages in the production, sub-licensing, and sale of cannabis or hemp products in the United States. The company’s patented skin delivery technology Invisicare, a patented polymer-based technology for topical and transdermal skin care products under the Ovation brand name. It also offers cannabis health and wellness products under the Invibe MD name; anti-aging products under the ARLO CBD name; and topical and transdermal creams and lotions with CBD, THC, and combinations, as well as hemp seed oil. The company was incorpor...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2017
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: OVAT

Financial Performance

In 2025, Ovation Science's revenue was 67,887, a decrease of -40.04% compared to the previous year's 113,215. Losses were -631,254, 38.4% more than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 18, 2026

Data Sources Report a data error